logo
搜索
菜单

Therapeuti的搜索结果

当前1/11页
排序: 最近更新
13.13: Pharmacokinetics in Pediatric Patients: Drug Metabolism 01:24 min
13.13: Pharmacokinetics in Pediatric Patients: Drug Metabolism
12.17: Pharmacokinetics: Drug–Drug Interactions 01:25 min
12.17: Pharmacokinetics: Drug–Drug Interactions
12.15: Therapeutic Drug Monitoring: Affecting Factors 01:29 min
12.15: Therapeutic Drug Monitoring: Affecting Factors
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
12.7: Dosage Interval and Administration Route: Determination Methods 01:19 min
12.7: Dosage Interval and Administration Route: Determination Methods
12.4: Dosage Regimen: Individualization 01:24 min
12.4: Dosage Regimen: Individualization
12.2: Dosage Regimens: Partial Pharmacokinetic Parameters 01:01 min
12.2: Dosage Regimens: Partial Pharmacokinetic Parameters
12.1: Dosage Regimens: Designs and Approaches 01:28 min
12.1: Dosage Regimens: Designs and Approaches
11.6: Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules 01:18 min
11.6: Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
11.5: Bioequivalence of Drugs: Drugs with Multiple Indications 01:09 min
11.5: Bioequivalence of Drugs: Drugs with Multiple Indications
11.3: Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence 01:19 min
11.3: Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
11.2: Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence 01:22 min
11.2: Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
9.12: Equivalence: In Vitro and In Vivo Bioequivalence 01:17 min
9.12: Equivalence: In Vitro and In Vivo Bioequivalence
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention 01:05 min
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
9.6: Measurement of Bioavailability: Pharmacokinetic Methods 01:30 min
9.6: Measurement of Bioavailability: Pharmacokinetic Methods
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients 01:15 min
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients
返回顶部